Burnjaro
39901, University Of Adelaide, SA 39901
14844760236
14844760236
Burnjaro is the brand name for tirzepatide, a medication developed primarily to treat type 2 diabetes. However, it has gained widespread popularity for its significant weight loss benefits. Manufactured by Eli Lilly, Burnjaro is a weekly injectable drug that mimics two naturally occurring hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)—that help regulate blood sugar levels and appetite.
What makes Burnjaro unique compared to similar drugs like Ozempic or Wegovy is its dual action on both GLP-1 and GIP receptors, which enhances its metabolic effects and promotes greater weight loss.
5 out of 5 from 1 reviews